These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25538755)

  • 41. Assessment of the association between XRCC1 Arg399Gln polymorphism and lung cancer in Chinese.
    Li Y; Huang Y; Cao YS; Zeng J; Tong WN; Xu SL; Zhuo AS
    Tumour Biol; 2013 Dec; 34(6):3681-5. PubMed ID: 23884604
    [TBL] [Abstract][Full Text] [Related]  

  • 42. XRCC1 polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.
    Hu Z; Hu X; Long J; Su L; Wei B
    Gene; 2013 Oct; 528(2):67-73. PubMed ID: 23872202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative assessment of the association between XRCC1 Arg399Gln and Arg194Trp polymorphisms and risk of cutaneous melanoma.
    Jiang H; Xu W; Zhang F; Wei L; Wang Y; Wang Y; Liu C
    Melanoma Res; 2016 Jun; 26(3):290-9. PubMed ID: 26967970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA repair genes XPD and XRCC1 polymorphisms and risk of end-stage renal disease in Egyptian population.
    Radwan WM; Elbarbary HS; Alsheikh NM
    Ren Fail; 2015 Feb; 37(1):122-8. PubMed ID: 25310768
    [TBL] [Abstract][Full Text] [Related]  

  • 45. XRCC1 Arg399Gln polymorphism contributes to increased risk of colorectal cancer in Chinese population.
    Tian Z; Li YL; Liu JG
    Mol Biol Rep; 2013 Jul; 40(7):4147-51. PubMed ID: 23712778
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The X-ray Repair Cross-Complementing Group 1 Arg399Gln Genetic Polymorphism and Risk of Hepatocellular Carcinoma in an Iranian Population.
    Bazgir A; Agha Gholizadeh M; Khosravi A; Mansour Samaei N
    Middle East J Dig Dis; 2018 Jan; 10(1):40-44. PubMed ID: 29682247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Involvement of the XRCC1 Arg399Gln gene polymorphism in the development of cervical carcinoma.
    Roszak A; Lianeri M; Jagodzinski PP
    Int J Biol Markers; 2011; 26(4):216-20. PubMed ID: 21928248
    [TBL] [Abstract][Full Text] [Related]  

  • 48. XRCC1 Arg399Gln polymorphism is not associated with breast cancer in Chinese.
    Guo S; Mao X; Ming L
    Int J Clin Exp Med; 2015; 8(7):10429-36. PubMed ID: 26379833
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DNA repair gene XRCC1 polymorphisms and susceptibility to childhood acute lymphoblastic leukemia: a meta-analysis.
    Du J; Lu C; Cui G; Chen Y; He J
    Chin J Cancer Res; 2013 Aug; 25(4):405-15. PubMed ID: 23997527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
    Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
    Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The association between XRCC1 Arg399Gln polymorphism and risk of leukemia in different populations: a meta-analysis of case-control studies.
    Wang F; Zhao Q; He HR; Zhai YJ; Lu J; Hu HB; Zhou JS; Yang YH; Li YJ
    Onco Targets Ther; 2015; 8():3277-87. PubMed ID: 26609240
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of XRCC1 Arg399Gln Polymorphism with Colorectal Cancer Risk: A HuGE Meta Analysis of 35 Studies.
    Forat-Yazdi M; Gholi-Nataj M; Neamatzadeh H; Nourbakhsh P; Shaker-Ardakani H
    Asian Pac J Cancer Prev; 2015; 16(8):3285-91. PubMed ID: 25921133
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between XRCC1 polymorphisms and the risk of cervical cancer: a meta-analysis based on 4895 subjects.
    Zeng X; Zhang Y; Yue T; Zhang T; Wang J; Xue Y; An R
    Oncotarget; 2017 Jan; 8(2):2249-2260. PubMed ID: 27903984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between the XRCC1 Arg399Gln polymorphism and risk of cervical carcinoma: a meta-analysis.
    Liu DY; Liang HC; Xiao XM
    Genet Mol Res; 2015 Aug; 14(3):9821-8. PubMed ID: 26345915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Genetic polymorphisms in X-ray repair cross-complementing gene 1 and susceptibility to papillary thyroid carcinoma].
    Zhu QX; Bian JC; Shen Q; Jiang F; Tang HW; Zhang HW; Wu Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):702-5. PubMed ID: 15555397
    [TBL] [Abstract][Full Text] [Related]  

  • 56. X-ray repair cross-complementing 1 polymorphism and prognosis of platinum-based chemotherapy in gastric and colorectal cancer: a meta-analysis.
    Wu H; Xu C; Chen G; Wang J
    J Gastroenterol Hepatol; 2014 May; 29(5):926-33. PubMed ID: 24224851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. XRCC1 R399Q polymorphism and colorectal cancer risk in the Chinese Han population: a meta-analysis.
    Qin CJ; Xu KW; Chen ZH; Zhai ET; He YL; Song XM
    Tumour Biol; 2015 Feb; 36(2):461-6. PubMed ID: 25582318
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of XRCC1 Arg399Gln polymorphism with bladder cancer susceptibility: a meta-analysis.
    Yang D; Liu C; Shi J; Wang N; Du X; Yin Q; Wang Y
    Gene; 2014 Jan; 534(1):17-23. PubMed ID: 24176953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. XRCC1 Arg399Gln gene polymorphism and breast cancer risk: a meta-analysis based on case-control studies.
    Wu K; Su D; Lin K; Luo J; Au WW
    Asian Pac J Cancer Prev; 2011; 12(9):2237-43. PubMed ID: 22296363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between the XRCC1 Arg399Gln polymorphism and head and neck cancer susceptibility: a meta-analysis based on case-control studies.
    Liu C; Yin Q; Jiao G; Zhou X; Ying M; Gao W; Hu J; Wei L; Wang N; Wang Y
    DNA Cell Biol; 2014 Jun; 33(6):378-87. PubMed ID: 24694255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.